您的位置: 首页 > 农业专利 > 详情页

Non- beta-lactam antibiotic
专利权人:
UNIVERSITY OF NOTRE DAME DU LAC
发明人:
申请号:
IL25136517
公开号:
IL251365D0
申请日:
2017.03.23
申请国别(地区):
IL
年份:
2017
代理人:
摘要:
The present invention provides a kind of newfound furodiazole antibiotic. The oxadiazoles can damage cell wall and synthesize and show active resisting gram-positive bacterium, such as staphylococcus aureus (Staphylococcus aureus), the staphylococcus aureus of staphylococcus aureus (MRSA) and vancomycin resistance and Nai Leinaizuoli including methicillin-resistant. For example, 5- (1H- indoles -5- bases) -3- (4- (4- (trifluoromethyl) phenoxy group) phenyl) -1,2,4- oxadiazoles (antibiotic 75b) is effectively, to show long half-lift, high distribution volume and low removing in the mouse model that MRSA infects. Antibiotic 75b has bactericidal effect and is that oral bio is compatible. This kind of antibiotic can be used as the therapeutic agent of resisting gram-positive bacterium such as MRSA infection.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充